Nitroglycerin USP 2.6mg Tablet.
Nidocard is indicated for the prophylaxis of angina pectoris due to coronary artery diseases. It is indicated for the supplementary treatment of heart failure refractory to digitalis and diuretic treatment. It is not suitable for treating an attack that has already started as the tablets will take too long to start working.
Nitroglycerin USP 2.6mg Tablet.
Nidocard is indicated for the prophylaxis of angina pectoris due to coronary artery diseases. It is indicated for the supplementary treatment of heart failure refractory to digitalis and diuretic treatment. It is not suitable for treating an attack that has already started as the tablets will take too long to start working.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.